Found: 35
Select item for more details and to access through your institution.
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 98, doi. 10.1007/s10637-018-0614-9
- By:
- Publication type:
- Article
PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers.
- Published in:
- BMC Medical Genomics, 2012, v. 5, n. 1, p. 44, doi. 10.1186/1755-8794-5-44
- By:
- Publication type:
- Article
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 9, p. 2217, doi. 10.1007/s12094-024-03440-5
- By:
- Publication type:
- Article
Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 4, p. 941, doi. 10.1007/s12094-022-02998-2
- By:
- Publication type:
- Article
Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 8488, doi. 10.3390/ijms24108488
- By:
- Publication type:
- Article
Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 11, p. 805, doi. 10.1093/jnci/djn151
- By:
- Publication type:
- Article
Initialization of adjuvant hormonal treatment for breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 205, n. 3, p. 589, doi. 10.1007/s10549-024-07292-z
- By:
- Publication type:
- Article
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 2, p. 151, doi. 10.1007/s10549-023-07002-1
- By:
- Publication type:
- Article
Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study).
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 2, p. 469, doi. 10.1007/s10549-020-05866-1
- By:
- Publication type:
- Article
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 115, doi. 10.1007/s10549-019-05296-8
- By:
- Publication type:
- Article
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 693, doi. 10.1007/s10549-018-05100-z
- By:
- Publication type:
- Article
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 1, p. 81, doi. 10.1007/s10549-016-3725-z
- By:
- Publication type:
- Article
Selecting postoperative adjuvant systemic therapy for early‐stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays.
- Published in:
- Journal of Surgical Oncology, 2024, v. 130, n. 2, p. 166, doi. 10.1002/jso.27692
- By:
- Publication type:
- Article
Selecting postoperative adjuvant systemic therapy for early‐stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays.
- Published in:
- Journal of Surgical Oncology, 2024, v. 130, n. 2, p. 166, doi. 10.1002/jso.27692
- By:
- Publication type:
- Article
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.
- Published in:
- Nature Communications, 2018, v. 9, p. 1, doi. 10.1038/s41467-018-05220-6
- By:
- Publication type:
- Article
Optimal [<sup>18</sup>F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266384
- By:
- Publication type:
- Article
Clinicopathological and molecular predictors of [<sup>18</sup>F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 9, p. 2733, doi. 10.1007/s00259-024-06683-0
- By:
- Publication type:
- Article
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 1, p. 23, doi. 10.1093/oncolo/oyac205
- By:
- Publication type:
- Article
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression.
- Published in:
- Oncologist, 2015, v. 20, n. 5, p. 474, doi. 10.1634/theoncologist.2014-0372
- By:
- Publication type:
- Article
Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis.
- Published in:
- Oncologist, 2015, v. 20, n. 2, p. 111, doi. 10.1634/theoncologist.2014-0379
- By:
- Publication type:
- Article
The Long-HER Study: Clinical and Molecular Analysis of Patients with HER2+ Advanced Breast Cancer Who Become Long-Term Survivors with Trastuzumab-Based Therapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109611
- By:
- Publication type:
- Article
Assessment of Prognostic and Therapeutic Factors in Male Breast Cancer: An Observational Study of a Southwest Spanish Single Center.
- Published in:
- Archives of Breast Cancer, 2020, v. 7, n. 4, p. 155, doi. 10.32768/abc.202074155-163
- By:
- Publication type:
- Article
New insights into the role of the immune microenvironment in breast carcinoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1529, doi. 10.3390/cancers15051529
- By:
- Publication type:
- Article
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Clinical validation of the EndoPredict test in node-positive chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM/9906 trial.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 2, p. 1, doi. 10.1186/bcr3642
- By:
- Publication type:
- Article
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 2, p. 457, doi. 10.1007/s10549-013-2416-2
- By:
- Publication type:
- Article
Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 133, n. 3, p. 917, doi. 10.1007/s10549-011-1864-9
- By:
- Publication type:
- Article
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 123, n. 1, p. 149, doi. 10.1007/s10549-009-0663-z
- By:
- Publication type:
- Article
Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 1, p. 169, doi. 10.1007/s10549-010-0860-9
- By:
- Publication type:
- Article
Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 157, doi. 10.1093/neuonc/noac144
- By:
- Publication type:
- Article
Cost-effectiveness analysis of docetaxel (Taxotere®) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancer.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 1, p. 41, doi. 10.1007/s12094-009-0309-y
- By:
- Publication type:
- Article